$PCRX Pacira BioSciences, Inc. Insider Trading Week 24/2016
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Pacira BioSciences, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Pacira BioSciences, Inc. in week 24/2016.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Williams Kristen Marie | CAO and General Cou ... | Grant | A | 0.00 | 8,750 | 0 | 15,650 | 6.9 K to 15.7 K (+126.81 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Weiland Robert J. | Chief Commercial Of ... | Option Exercise | A | 40.34 | 10,000 | 403,400 | 10,000 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Option Exercise | A | 40.34 | 66,250 | 2,672,525 | 66,250 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | STACK DAVID M | CEO and Chairman | Grant | A | 0.00 | 33,125 | 0 | 33,410 | 285 to 33.4 K (+11,622.81 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Option Exercise | A | 40.34 | 32,500 | 1,311,050 | 32,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Scibetta James S | President & CFO | Grant | A | 0.00 | 16,250 | 0 | 26,754 | 10.5 K to 26.8 K (+154.70 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Option Exercise | A | 40.34 | 6,250 | 252,125 | 6,250 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Riker Lauren Bullaro | Vice President, Fin ... | Grant | A | 0.00 | 3,125 | 0 | 8,453 | 5.3 K to 8.5 K (+58.65 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Grant | A | 0.00 | 8,750 | 0 | 10,250 | 1.5 K to 10.3 K (+583.33 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 1,488 | 0 | 6,133 | 4.6 K to 6.1 K (+32.03 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Jones James B | SVP & Chief Medical ... | Grant | A | 0.00 | 8,750 | 0 | 10,250 | 1.5 K to 10.3 K (+583.33 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Option Exercise | A | 40.34 | 17,500 | 705,950 | 17,500 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Braunstein Scott | SVP, Strategy & Cor ... | Grant | A | 0.00 | 8,750 | 0 | 10,750 | 2 K to 10.8 K (+437.50 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | WINGER DENNIS L | Director | Grant | A | 0.00 | 1,488 | 0 | 6,133 | 4.6 K to 6.1 K (+32.03 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | PACE GARY W | Director | Grant | A | 0.00 | 1,488 | 0 | 22,180 | 20.7 K to 22.2 K (+7.19 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | LONGENECKER JOHN P PHD | Director | Grant | A | 0.00 | 1,488 | 0 | 3,788 | 2.3 K to 3.8 K (+64.70 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Kronenfeld Mark A. | Director | Grant | A | 0.00 | 1,488 | 0 | 4,438 | 3 K to 4.4 K (+50.44 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | HASTINGS PAUL J | Director | Grant | A | 0.00 | 1,488 | 0 | 3,205 | 1.7 K to 3.2 K (+86.66 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Greenstreet Yvonne | Director | Grant | A | 0.00 | 1,488 | 0 | 3,488 | 2 K to 3.5 K (+74.40 %) |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Option Exercise | A | 40.34 | 2,975 | 120,012 | 2,975 | |
| Jun 17 2016 | PCRX | Pacira Pharmaceuti ... | Brege Laura | Director | Grant | A | 0.00 | 1,488 | 0 | 2,488 | 1,000 to 2.5 K (+148.80 %) |